Heterogeneity in limb fatty acid kinetics in type 2 diabetes

Diabetologia

Volumn 48, Issue 5, 2005, Pages 938-945

  Sacchetti, M ^a,b   Olsen, D B ^a,b   Saltin, B ^a,b   Van Hall, G ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Diabetes; Fatty acid; Limb; Skeletal muscle

Indexed keywords

FATTY ACID; PALMITIC ACID;

ADULT; ARM; ARTICLE; BODY MASS; CLAMP; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; HUMAN; HYPERINSULINEMIA; KINETICS; LEG; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKELETAL MUSCLE;

ARM; BIOLOGICAL TRANSPORT; BLOOD FLOW VELOCITY; BODY COMPOSITION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMORAL ARTERY; FEMORAL VEIN; HUMANS; LEG; MALE; MIDDLE AGED; PALMITIC ACID; REFERENCE VALUES;

EID: 20044362598     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1727-1     Document Type: Article

References (45)

1. Skowronski R, Hollenbeck CB, Varasteh BB, Chen YD, Reaven GM (1991) Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes. Diabet Med 8:330-333
2. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024
3. Boden G, Jadali F, White J et al (1991) Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88:960-966
4. Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10
5. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92:91-98
6. Santomauro AT, Boden G, Silva V et al (1999) Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and non-diabetic subjects. Diabetes 48:1836-1841
7. Kelley DE, Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349-2356
8. Blaak EE, Wagenmakers AJ, Glatz JF et al (2000) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E146-E154
9. Blaak EE, Wagenmakers AJ (2002) The fate of [U-(13)C] palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects. Diabetes 51:784-789
10. Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 [Suppl 3]:14-23
11. Kelley DE, Goodpaster BH (2001) Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24:933-941
12. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147-152
13. Manson JE, Rimm EB, Stampfer MJ (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774-778
14. Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, Galbo H (1995) Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 44:1010-1020
15. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F (2004) Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 53:294-305
16. Hagstrom-Toft E, Qvisth V, Nennesmo I et al (2002) Marked heterogeneity of human skeletal muscle lipolysis at rest. Diabetes 51:3376-3383
17. Fuller NJ, Laskey MA, Elia M (1992) Assessment of the composition of major body regions by dual-energy X-ray absorptiometry (DEXA), with special reference to limb muscle mass. Clin Physiol 12:253-266
18. Radegran G (1997) Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 83:1383-1388
19. van Hall G, Gonzalez-Alonso J, Sacchetti M, Saltin B (1999) Skeletal muscle substrate metabolism during exercise: methodological considerations. Proc Nutr Soc 58:899-912
20. Patterson BW, Zhao G, Elias N, Hachey DL, Klein S (1999) Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 40:2118-2124
21. Van Hall G, Bulow J, Sacchetti M, Al Mulla N, Lyngso D, Simonsen L (2002) Regional fat metabolism in human splanchnic and adipose tissues; the effect of exercise. J Physiol 543:1033-1046
22. Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420-430
23. Holm C (2003) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 31:1120-1124
24. Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD (2001) Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 280:E1000-E1006
25. Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205-213
26. Miles JM, Wooldridge D, Grellner WJ et al (2003) Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes 52:675-681
27. Kelley DE, Reilly JP, Veneman T, Mandarino LJ (1990) Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am J Physiol 258:E923-E929
28. Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR (2003) Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. Am J Physiol Endocrinol Metab 285:E354-E362
29. Gaster M, Rustan AC, Aas V, Beck-Nielsen H (2004) Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53:542-548
30. Meek SE, Nair KS, Jensen MD (1999) Insulin regulation of regional free fatty acid metabolism. Diabetes 48:10-14
31. Capaldo B, Napoli R, Di Marino L, Picardi A, Riccardi G, Sacca L (1988) Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance. J Clin Endocrinol Metab 67:893-898
32. Dyck DJ, Steinberg G, Bonen A (2001) Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle. Am J Physiol Endocrinol Metab 281:E600-E607
33. Luiken JJ, Koonen DP, Willems J et al (2002) Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51:3113-3119
34. Bonen A, Luiken JJ, Glatz JF (2002) Regulation of fatty acid transport and membrane transporters in health and disease. Mol Cell Biochem 239:181-192
35. Hajri T, Abumrad NA (2002) Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 22:383-415
36. Bruce CR, Anderson MJ, Carey AL et al (2003) Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88:5444-5451
37. van Hall G, Sacchetti M, Radegran G, Saltin B (2002) Human skeletal muscle fatty acid and glycerol metabolism during rest, exercise and recovery. J Physiol 543:1047-1058
38. Coppack SW, Persson M, Judd RL, Miles JM (1999) Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo. Am J Physiol 276:E233-E240
39. Jensen MD (1997) Lipolysis: contribution from regional fat. Annu Rev Nutr 17:127-139
40. Bolinder J, Kerckhoffs DA, Moberg E, Hagstrom-Toft E, Arner P (2000) Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes 49:797-802
41. Hagstrom-Toft E, Thorne A, Reynisdottir S et al (2001) Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo. Diabetes 50:1604-1611
42. Sjostrand M, Gudbjornsdottir S, Holmang A, Strindberg L, Ekberg K, Lonnroth P (2002) Measurements of interstitial muscle glycerol in normal and insulin-resistant subjects. J Clin Endocrinol Metab 87:2206-2211
43. Navegantes LC, Sjostrand M, Gudbjornsdottir S, Strindberg L, Elam M, Lonnroth P (2003) Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin. J Clin Endocrinol Metab 88:5515-5520
44. Jacob S, Hauer B, Becker R et al (1999) Lipolysis in skeletal muscle is rapidly regulated by low physiological doses of insulin. Diabetologia 42:1171-1174
45. Stumvoll M, Jacob S, Wahl HG et al (2000) Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab 85:3740-3745